Literature DB >> 3921758

Gaucher disease (type 1): physical and kinetic properties of liposomal and soluble 'acid' beta-glucosidase.

M Carroll.   

Abstract

'Acid' beta-glucosidase of human spleen, from either normal controls or patients with type 1 (adult) Gaucher disease, was incorporated into phosphatidylcholine liposomes. The non-incorporated (soluble) Gaucher-enzyme had a higher apparent molecular weight than had the corresponding control. Liposomal 'acid' beta-glucosidase prepared from Gaucher-spleen was more thermostable than was the corresponding normal enzyme; it was also stimulated by acidic lipids to a much lesser extent. The results suggest that the genetic mutation in type 1 (adult) Gaucher disease has multiple effects on the glycoprotein form of 'acid' beta-glucosidase.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3921758     DOI: 10.1007/bf01805482

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  13 in total

1.  Gaucher disease: isolation and comparison of normal and mutant glucocerebrosidase from human spleen tissue.

Authors:  P G Pentchev; R O Brady; H E Blair; D E Britton; S H Sorrell
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

2.  Glucocerebrosidase: reconstitution from macromolecular components depends on acidic phospholipids.

Authors:  M W Ho; N D Light
Journal:  Biochem J       Date:  1973-11       Impact factor: 3.857

3.  Immunological and catalytic quantitation of splenic glucocerebrosidase from the three clinical forms of Gaucher disease.

Authors:  P G Pentchev; B Neumeyer; L Svennerholm; C G Groth; R O Brady
Journal:  Am J Hum Genet       Date:  1983-07       Impact factor: 11.025

4.  Physical and kinetic properties of beta-glucosidase in Gaucher disease.

Authors:  A Karazeh; M Carroll
Journal:  J Inherit Metab Dis       Date:  1983       Impact factor: 4.982

5.  Purification and properties of a heat-stable glucocerebrosidase activating factor from control and Gaucher spleen.

Authors:  S P Peters; P Coyle; C J Coffee; R H Glew
Journal:  J Biol Chem       Date:  1977-01-25       Impact factor: 5.157

6.  Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.

Authors:  E I Ginns; R O Brady; S Pirruccello; C Moore; S Sorrell; F S Furbish; G J Murray; J Tager; J A Barranger
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

7.  An improved procedure for diagnosis of Gaucher disease using cultured skin fibroblasts and the chromogenic substrate, 2-hexadecanoylamino-4-nitrophenyl-beta-D-glucopyranoside.

Authors:  R J Barns; A E Clague
Journal:  Clin Chim Acta       Date:  1982-03-26       Impact factor: 3.786

8.  Enzymic differentiation of neurologic and nonneurologic forms of Gaucher's disease.

Authors:  R H Glew; L B Daniels; L S Clark; S W Hoyer
Journal:  J Neuropathol Exp Neurol       Date:  1982-11       Impact factor: 3.685

9.  Tay-Sachs disease: generalized absence of a beta-D-N-acetylhexosaminidase component.

Authors:  S Okada; J S O'Brien
Journal:  Science       Date:  1969-08-15       Impact factor: 47.728

10.  Isoenzymes of membrane-bound beta-glucosidase of human spleen.

Authors:  M Yaqoob; M Carroll
Journal:  Biochem J       Date:  1980-02-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.